A teenager with mixed connective tissue disease presenting with an acute coronary syndrome

Vascular Medicine

Volumn 9, Issue 1, 2004, Pages 31-34

  Jang, James J ^a   Olin, Jeffrey W ^a   Fuster, Valentin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Mixed connective tissue disease; Myocardial infarction; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; EPTIFIBATIDE; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; INSULIN; LABETALOL; LISINOPRIL; METOPROLOL;

ADULT; ANAMNESIS; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; MIXED CONNECTIVE TISSUE DISEASE; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADOLESCENT; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MIXED CONNECTIVE TISSUE DISEASE; MYOCARDIAL INFARCTION;

EID: 3042855063     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x04vm519cr     Document Type: Article

References (24)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 1876-90.
3. Lie JT. Coronary vasculitis. Arch Pathol Lab Med 1987; 111: 224-33.
4. Aufderheide AC, Henke BW, Parker EH. Granulomatous coronary arteritis (Takayasu's disease). Arch Pathol Lab Med 1981; 105: 647-49.
5. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-89.
6. Karrar A, Sequeira W, Block JA. Coronary artery disease in systemic lupus erythematosus: a review of the literature. Semin Athritis Rheum 2001; 30: 436-43.
7. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52 148-59.
8. Langley RL, Treadwell EL. Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review. J Natl Med Assoc 1994; 86: 149-53.
9. Lash AD, Wittman AL, Quismorio FP Jr. Myocarditis in mixed connective tissue disease; clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum 1986; 15: 288-96.
10. Hammann C, Genton CY, Delabays A et al. Myocarditis of mixed connective tissue disease: favorable outcome after intravenous pulsed cyclophosphamide. Clin Rheumatol 1999; 18: 85-87.
11. Oetgen WJ, Mutter ML, Lawless OJ, Davia JE. Cardiac abnormalities in mixed connective tissue disease. Chest 1983; 83: 185-88.
12. Rebollar-Gonzalez V, Torre-Delgadillo A, Orea-Tejada A et al. Cardiac conduction disturbances in mixed connective tissue disease. Rev Invest Clin 2001; 53: 330-34.
13. Alpert MA, Goldberg SH, Singsen BH et al. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 1983; 68: 1182-93.
14. Singsen BH, Bernstein BH, Kornreich HK et al. Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr 1977; 90: 893-900.
15. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 1980; 59: 239-48.
16. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001; 14: 83S-89S.
17. Filep JG, Bodolay E, Sipka S et al. Plasma endothelin correlates with antiendothelial antibodies with mixed connective tissue disease. Circulation 1995; 92: 2969-74.
18. Bodolay E, Bojan F, Szegedi G, Stenszky V, Farid NR. Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol Lett 1989; 20: 163-67.
19. Slovut D, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350: 1862-71.
20. Son JW, Koh KK, Dang Q, Choi IS, Shin EK. Recurrent restenosis following stent and rotational atherectomy of coronary artery stenosis in Takayasu's arteritis. Int J Cardiol 1998; 65: 295-300.
21. Ishii M, Ueno T, Ikeda H et al. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease. Circulation 2002; 105: 3004-10.
22. Lincoff AM, Kereiakes DJ, Mascelli MA et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001; 104; 163-67.
23. Yutani C, Imakita M, Ishibashi-Ueda H, Tsukamoto Y, Nishida N, Ikeda Y. Coronary atherosclerosis and interventions: pathological sequences and restenosis. Pathol Int 1999; 49: 273-90.
24. Van der Wal AC, Becker AE, van der Loos CM et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89: 36-44.